Transforming Growth Factor-β Requires Its Target Plasminogen Activator Inhibitor-1 for Cytostatic Activity
Open Access
- 1 September 2008
- journal article
- research article
- Published by Elsevier BV in Online Journal of Public Health Informatics
- Vol. 283 (36), 24308-24313
- https://doi.org/10.1074/jbc.m803341200
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescenceNature, 2006
- The Tumor Suppressor Smad4 Is Required for Transforming Growth Factor β–Induced Epithelial to Mesenchymal Transition and Bone Metastasis of Breast Cancer CellsCancer Research, 2006
- SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADSAnnual Review of Cell and Developmental Biology, 2005
- Smad4 Dependency Defines Two Classes of Transforming Growth Factor β (TGF-β) Target Genes and Distinguishes TGF-β-Induced Epithelial-Mesenchymal Transition from Its Antiproliferative and Migratory ResponsesMolecular and Cellular Biology, 2005
- Cytostatic and apoptotic actions of TGF-β in homeostasis and cancerNature Reviews Cancer, 2003
- Urokinase Plasminogen Activator SystemClinical Orthopaedics and Related Research, 2003
- Pooled analysis of prognostic impact of uPA and PAI-1 in breast cancer patientsThrombosis and Haemostasis, 2003
- TGF-β signaling in cancer – a double-edged swordTrends in Cell Biology, 2001
- Transforming Growth Factor-β Modulates Plasminogen Activator Activity and Plasminogen Activator Inhibitor Type-1 Expression in Human Keratinocytes In VitroJournal of Investigative Dermatology, 1990
- Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylationCell, 1990